 Setareh Salehi Omran
Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 24 | 2026 | 1209 | 3.550 |
Why?
| | Vertebral Artery Dissection | 10 | 2026 | 29 | 2.500 |
Why?
| | Carotid Artery, Internal, Dissection | 9 | 2026 | 15 | 2.110 |
Why?
| | Brain Ischemia | 4 | 2020 | 351 | 1.160 |
Why?
| | Endocarditis | 2 | 2019 | 38 | 1.150 |
Why?
| | Anticoagulants | 8 | 2025 | 725 | 1.120 |
Why?
| | Neurology | 2 | 2024 | 113 | 0.930 |
Why?
| | Fibrinolytic Agents | 3 | 2024 | 287 | 0.760 |
Why?
| | Cerebral Arteries | 1 | 2022 | 58 | 0.720 |
Why?
| | Neurologists | 1 | 2020 | 22 | 0.660 |
Why?
| | Thrombophilia | 1 | 2021 | 90 | 0.650 |
Why?
| | Diagnostic Tests, Routine | 1 | 2021 | 110 | 0.630 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2020 | 70 | 0.610 |
Why?
| | Posterior Leukoencephalopathy Syndrome | 3 | 2023 | 11 | 0.590 |
Why?
| | Thrombectomy | 2 | 2022 | 77 | 0.590 |
Why?
| | Intracranial Hemorrhages | 2 | 2024 | 99 | 0.590 |
Why?
| | Atrial Fibrillation | 2 | 2024 | 508 | 0.570 |
Why?
| | Cerebral Angiography | 1 | 2018 | 116 | 0.560 |
Why?
| | Platelet Aggregation Inhibitors | 5 | 2025 | 484 | 0.530 |
Why?
| | Computed Tomography Angiography | 1 | 2018 | 139 | 0.520 |
Why?
| | Ischemic Attack, Transient | 3 | 2023 | 71 | 0.510 |
Why?
| | Magnetic Resonance Angiography | 1 | 2018 | 251 | 0.490 |
Why?
| | Cerebrovascular Circulation | 1 | 2018 | 271 | 0.480 |
Why?
| | Thrombolytic Therapy | 3 | 2024 | 156 | 0.460 |
Why?
| | Pregnancy Complications | 1 | 2020 | 588 | 0.440 |
Why?
| | Internship and Residency | 1 | 2023 | 1244 | 0.390 |
Why?
| | Hospitalization | 3 | 2020 | 2293 | 0.380 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1353 | 0.340 |
Why?
| | Brain | 2 | 2023 | 2875 | 0.330 |
Why?
| | Opioid-Related Disorders | 1 | 2019 | 574 | 0.330 |
Why?
| | Venous Thrombosis | 2 | 2022 | 194 | 0.320 |
Why?
| | Risk Factors | 15 | 2026 | 10593 | 0.310 |
Why?
| | Retrospective Studies | 20 | 2026 | 16626 | 0.300 |
Why?
| | Humans | 37 | 2026 | 142526 | 0.300 |
Why?
| | Endovascular Procedures | 2 | 2024 | 372 | 0.290 |
Why?
| | Intracranial Embolism | 2 | 2019 | 34 | 0.280 |
Why?
| | Smoking Cessation | 2 | 2023 | 434 | 0.270 |
Why?
| | Arteries | 3 | 2024 | 260 | 0.260 |
Why?
| | Diagnostic Errors | 2 | 2024 | 176 | 0.250 |
Why?
| | Aged | 17 | 2026 | 25117 | 0.250 |
Why?
| | Young Adult | 7 | 2024 | 13878 | 0.240 |
Why?
| | Middle Aged | 19 | 2026 | 35049 | 0.240 |
Why?
| | Fibromuscular Dysplasia | 1 | 2025 | 9 | 0.240 |
Why?
| | Treatment Outcome | 9 | 2025 | 11298 | 0.230 |
Why?
| | Female | 25 | 2026 | 76624 | 0.230 |
Why?
| | Adult | 16 | 2026 | 39715 | 0.220 |
Why?
| | Aged, 80 and over | 8 | 2023 | 8020 | 0.220 |
Why?
| | Smoking | 3 | 2023 | 1579 | 0.220 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2024 | 83 | 0.210 |
Why?
| | Vasospasm, Intracranial | 1 | 2023 | 19 | 0.200 |
Why?
| | Noma | 1 | 2023 | 2 | 0.200 |
Why?
| | Renal Colic | 1 | 2022 | 4 | 0.190 |
Why?
| | Cerebrovascular Disorders | 1 | 2023 | 100 | 0.190 |
Why?
| | Cerebral Veins | 1 | 2022 | 16 | 0.190 |
Why?
| | Status Epilepticus | 1 | 2023 | 54 | 0.190 |
Why?
| | Intracranial Thrombosis | 1 | 2022 | 18 | 0.180 |
Why?
| | Dabigatran | 1 | 2022 | 29 | 0.180 |
Why?
| | Recurrence | 4 | 2026 | 1111 | 0.180 |
Why?
| | Administration, Oral | 2 | 2022 | 835 | 0.170 |
Why?
| | Registries | 5 | 2026 | 2227 | 0.170 |
Why?
| | Warfarin | 1 | 2022 | 168 | 0.170 |
Why?
| | Education, Medical | 1 | 2024 | 275 | 0.170 |
Why?
| | Male | 19 | 2026 | 70910 | 0.170 |
Why?
| | Tissue Plasminogen Activator | 2 | 2024 | 239 | 0.160 |
Why?
| | Diagnostic Techniques, Cardiovascular | 1 | 2020 | 11 | 0.160 |
Why?
| | United States | 7 | 2024 | 15447 | 0.160 |
Why?
| | Drug Substitution | 1 | 2020 | 62 | 0.160 |
Why?
| | Fellowships and Scholarships | 1 | 2023 | 328 | 0.160 |
Why?
| | Mobile Health Units | 1 | 2019 | 20 | 0.160 |
Why?
| | Drug Utilization | 1 | 2020 | 166 | 0.150 |
Why?
| | Ambulances | 1 | 2019 | 53 | 0.150 |
Why?
| | Pregnancy | 3 | 2024 | 7113 | 0.150 |
Why?
| | Health Care Surveys | 1 | 2020 | 562 | 0.140 |
Why?
| | Geography | 1 | 2019 | 200 | 0.140 |
Why?
| | Thrombosis | 1 | 2022 | 399 | 0.140 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 618 | 0.140 |
Why?
| | Time-to-Treatment | 1 | 2019 | 227 | 0.130 |
Why?
| | Troponin | 1 | 2017 | 45 | 0.130 |
Why?
| | Predictive Value of Tests | 2 | 2024 | 2081 | 0.130 |
Why?
| | Health Surveys | 1 | 2019 | 511 | 0.130 |
Why?
| | Incidence | 2 | 2024 | 2826 | 0.120 |
Why?
| | Survivors | 1 | 2020 | 502 | 0.120 |
Why?
| | Sex Factors | 2 | 2020 | 2074 | 0.120 |
Why?
| | Medication Adherence | 1 | 2020 | 513 | 0.120 |
Why?
| | Stroke Volume | 1 | 2019 | 606 | 0.120 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2019 | 376 | 0.120 |
Why?
| | Ventricular Function, Left | 1 | 2019 | 517 | 0.120 |
Why?
| | Adolescent | 3 | 2020 | 22326 | 0.120 |
Why?
| | Myocardial Infarction | 1 | 2020 | 1067 | 0.100 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2251 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2020 | 3604 | 0.090 |
Why?
| | Age Factors | 1 | 2019 | 3316 | 0.090 |
Why?
| | Administration, Intravenous | 2 | 2024 | 172 | 0.080 |
Why?
| | Depression | 1 | 2020 | 1503 | 0.080 |
Why?
| | Inpatients | 2 | 2024 | 517 | 0.080 |
Why?
| | New York City | 2 | 2019 | 88 | 0.080 |
Why?
| | Risk Assessment | 3 | 2024 | 3562 | 0.080 |
Why?
| | Databases, Factual | 2 | 2024 | 1458 | 0.070 |
Why?
| | Seizures | 2 | 2023 | 452 | 0.070 |
Why?
| | Cohort Studies | 3 | 2025 | 5858 | 0.070 |
Why?
| | Odds Ratio | 2 | 2020 | 1057 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1642 | 0.060 |
Why?
| | Medicare | 2 | 2020 | 808 | 0.050 |
Why?
| | Delayed Diagnosis | 1 | 2024 | 91 | 0.050 |
Why?
| | Time Factors | 2 | 2024 | 7006 | 0.050 |
Why?
| | Logistic Models | 2 | 2020 | 2102 | 0.050 |
Why?
| | Middle Cerebral Artery | 1 | 2023 | 55 | 0.050 |
Why?
| | American Heart Association | 1 | 2024 | 300 | 0.050 |
Why?
| | Vasoconstriction | 1 | 2023 | 215 | 0.050 |
Why?
| | Child | 1 | 2020 | 22562 | 0.040 |
Why?
| | Varenicline | 1 | 2020 | 28 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2024 | 952 | 0.040 |
Why?
| | Bupropion | 1 | 2020 | 45 | 0.040 |
Why?
| | Urban Health | 1 | 2019 | 95 | 0.040 |
Why?
| | Comorbidity | 1 | 2024 | 1678 | 0.040 |
Why?
| | Observational Studies as Topic | 1 | 2020 | 126 | 0.040 |
Why?
| | Prospective Studies | 2 | 2024 | 7862 | 0.040 |
Why?
| | Prevalence | 1 | 2026 | 2817 | 0.040 |
Why?
| | Hemorrhage | 1 | 2024 | 798 | 0.040 |
Why?
| | Nutrition Surveys | 1 | 2020 | 281 | 0.040 |
Why?
| | Patient Discharge | 1 | 2024 | 920 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 5700 | 0.030 |
Why?
| | Communication | 1 | 2024 | 949 | 0.030 |
Why?
| | Cerebral Hemorrhage | 1 | 2017 | 118 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2017 | 527 | 0.030 |
Why?
| | Up-Regulation | 1 | 2017 | 857 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1508 | 0.030 |
Why?
| | Patient Safety | 1 | 2017 | 339 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2022 | 5270 | 0.020 |
Why?
| | Biomarkers | 1 | 2017 | 4207 | 0.020 |
Why?
|
|
Salehi Omran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|